A Kinome Screen Identifies Checkpoint Kinase 1 (CHK1) as a Sensitizer for RRM1-Dependent Gemcitabine Efficacy
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference34 articles.
1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;JH Schiller;N Engl J Med,2002
2. Single-agent gemcitabine is active in previously treated breast cancer;M Spielmann;Oncology,2001
3. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer;H Oettle;J Am Med Assoc,2007
4. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;H von der Maase;J Clin Oncol,2005
5. Gemcitabine: preclinical pharmacology and mechanism of action;W Plunkett;Semin Oncol,1996
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HPO iron chelator, CP655, causes the G1/S phase cell cycle block via p21 upregulation;Immunity, Inflammation and Disease;2020-08-31
2. Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors;Cancers;2020-03-12
3. Preclinical Profiles and Contexts for CHK1 and CHK2 Inhibitors;Cancer Drug Discovery and Development;2018
4. Cancer TARGETases: DSB repair as a pharmacological target;Pharmacology & Therapeutics;2016-05
5. Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung Cancer;Proteomes;2016-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3